Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes.
|
J Antimicrob Chemother
|
1993
|
1.77
|
2
|
Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study.
|
Scand J Infect Dis
|
1991
|
1.45
|
3
|
Plasma levels of protein S, protein C, and factor X: effects of sex, hormonal state and age.
|
Thromb Haemost
|
1995
|
1.40
|
4
|
Determination of plasma protein S--the protein cofactor of activated protein C.
|
Thromb Haemost
|
1985
|
1.31
|
5
|
Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations.
|
Lancet
|
1990
|
1.23
|
6
|
Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans.
|
Crit Care Med
|
1992
|
1.11
|
7
|
Anti-streptokinase antibodies inhibit fibrinolytic effects of anistreplase in acute myocardial infarction.
|
Am J Cardiol
|
1993
|
1.04
|
8
|
Association of smooth muscle cell tissue factor with caveolae.
|
Blood
|
1996
|
0.97
|
9
|
Basal tissue factor expression in endothelial cell cultures is caused by contaminating smooth muscle cells. Reduction by using chymotrypsin instead of collagenase.
|
Thromb Res
|
1995
|
0.89
|
10
|
Tumor necrosis factor alpha-induced endothelial tissue factor is located on the cell surface rather than in the subendothelial matrix.
|
Blood
|
1994
|
0.85
|
11
|
Fibrinolytic activity in the abdominal cavity of rats with faecal peritonitis.
|
Br J Surg
|
1994
|
0.79
|
12
|
Association of endothelial tissue factor and thrombomodulin with caveolae.
|
Blood
|
1996
|
0.79
|
13
|
Patterns of cytokines, plasma endotoxin, and acute phase proteins during the treatment of severe sepsis in humans.
|
Prog Clin Biol Res
|
1991
|
0.78
|
14
|
Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis.
|
J Am Coll Surg
|
1994
|
0.78
|
15
|
A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functions.
|
J Immunol Methods
|
2000
|
0.78
|
16
|
Immunoradiometric assays for human coagulation factor VII using polyclonal antibodies against the Ca(II)-dependent and Ca(II)-independent conformation.
|
Thromb Haemost
|
1986
|
0.77
|
17
|
Lowered APC-sensitivity ratio related to increased factor VIII-clotting activity.
|
Thromb Haemost
|
1995
|
0.77
|
18
|
Coagulation and fibrinolytic responses of human peritoneal fluid and plasma to bacterial peritonitis.
|
Br J Surg
|
1996
|
0.77
|
19
|
Pharmacokinetics of human recombinant tissue-type plasminogen activator, administered intra-abdominally, in a rat peritonitis model.
|
Eur Surg Res
|
1996
|
0.77
|
20
|
Application of factor VII-Sepharose affinity chromatography in the purification of human tissue factor apoprotein.
|
Thromb Res
|
1986
|
0.76
|
21
|
Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans.
|
Scand J Infect Dis
|
1992
|
0.76
|
22
|
Streptokinase antibodies are of clinical importance and they can be measured in half an hour by a simple enzyme-linked immunosorbent assay.
|
Br Heart J
|
1994
|
0.75
|
23
|
Effects of hyperthermic isolated limb perfusion with recombinant tumor necrosis factor alpha and melphalan on the human fibrinolytic system.
|
Cancer Res
|
1996
|
0.75
|
24
|
The clinical expression of hereditary protein C and protein S deficiency: a relation to clinical thrombotic risk factors and to levels of protein C and protein S?
|
Blood Coagul Fibrinolysis
|
1993
|
0.75
|
25
|
Solid phase immunoradiometric assay of activated human coagulation factor IX.
|
Thromb Res
|
1987
|
0.75
|
26
|
Hemoperfusion during coronary angioplasty: first European experience with a new hemoperfusion pump.
|
Artif Organs
|
1994
|
0.75
|
27
|
In-vivo evaluation of the "HIA-VAD": a new German ventricular assist device.
|
Thorac Cardiovasc Surg
|
1994
|
0.75
|
28
|
Sensitivity to activated protein C; influence of oral contraceptives and sex.
|
Thromb Haemost
|
1995
|
0.75
|
29
|
Severe bleeding caused by an inhibitor to coagulation factor V: a case report.
|
Blood Coagul Fibrinolysis
|
1994
|
0.75
|